Azithromycin 500 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1Z70
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,260
Award facts
- Contract value 100% obligated
- $18,260.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,260.02 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on February 4, 2026, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which carries an ultimate completion date of February 5, 2026, was competitively awarded with no set-aside designation. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, serving as the contract vehicle for this pharmaceutical procurement.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with an extensive portfolio of drug supply contracts supporting the Defense Health Agency, U.S. Coast Guard, and other government medical institutions. Azithromycin, a macrolide antibiotic commonly used for bacterial infections, represents one element of the company's broad pharmaceutical supply capabilities under the DLA master contract. The rapid completion timeline—with award and completion dates separated by a single day—reflects the urgent nature of this medical supply need within the federal healthcare system.
Quick answers
Who was awarded contract SPE2DR26F1Z70?
SPE2DR26F1Z70 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F1Z70 worth?
The government has obligated $18,260 on SPE2DR26F1Z70.
Is contract SPE2DR26F1Z70 an order under another contract?
Yes. SPE2DR26F1Z70 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Z70 competed?
The extent of competition for SPE2DR26F1Z70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award